Phillips Milk of Magnesia data "inadequate" to support stool softener indication -- FDA.
This article was originally published in The Tan Sheet
Executive Summary
PHILLIPS' MILK OF MAGNESIA DATA "INADEQUATE" to support a stool softener laxative indication, FDA said in an Aug. 3 response to a 1994 citizen petition from Sterling Health. The agency said it has reviewed the petition and "finds the data inadequate to support the effectiveness of 1,200 mg of magnesium hydroxide as a Category I [safe and effective] stool softener laxative." The Sterling U.S. business was acquired by Bayer in the autumn of 1994.
You may also be interested in...
Laxatives/Drug Interaction, Ingredient Combination Revisited In Comments
The drug interaction warning being planned for OTC laxatives should recommend consulting a health care professional before taking the products with prescription medications, not all drugs, Procter & Gamble states in recent comments to FDA
Laxatives/Drug Interaction, Ingredient Combination Revisited In Comments
The drug interaction warning being planned for OTC laxatives should recommend consulting a health care professional before taking the products with prescription medications, not all drugs, Procter & Gamble states in recent comments to FDA
Laxatives/Drug Interaction, Ingredient Combination Revisited In Comments
The drug interaction warning being planned for OTC laxatives should recommend consulting a health care professional before taking the products with prescription medications, not all drugs, Procter & Gamble states in recent comments to FDA